Ken Griffin Johnson & Johnson Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Johnson & Johnson stock. As of the latest transaction made, Citadel Advisors LLC holds 2,646,100 shares of JNJ stock, worth $405 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

2,646,100

Previous 3,149,300 15.98%

Holding current value

$405 Million

Previous $498 Million 22.37%

% of portfolio

0.08%

Previous 0.1%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$144.38 - $157.78 $123 Million - $135 Million	853,507 Added 141.87%	1,455,131 $213 Million
Q1 2024 May 15, 2024	BUY	$155.22 - $162.74 $82.9 Million - $86.9 Million	533,850 Added 787.69%	601,624 $95.2 Million
Q4 2023 Feb 14, 2024	SELL	$145.6 - $158.88 $56.7 Million - $61.9 Million	-389,642 Reduced 85.18%	67,774 $10.6 Million
Q3 2023 Nov 14, 2023	SELL	$155.75 - $174.48 $276 Million - $310 Million	-1,774,854 Reduced 79.51%	457,416 $71.2 Million
Q2 2023 Aug 14, 2023	BUY	$154.35 - $166.11 $86 Million - $92.6 Million	557,451 Added 33.28%	2,232,270 $369 Million
Q1 2023 May 15, 2023	BUY	$151.05 - $180.26 $215 Million - $257 Million	1,424,288 Added 568.51%	1,674,819 $260 Million
Q4 2022 Feb 14, 2023	BUY	$160.2 - $179.79 $34.9 Million - $39.2 Million	218,146 Added 673.6%	250,531 $44.3 Million
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $50.7 Million - $56.4 Million	-314,421 Reduced 90.66%	32,385 $5.29 Million
Q2 2022 Aug 15, 2022	SELL	$168.19 - $186.01 $123 Million - $136 Million	-731,210 Reduced 67.83%	346,806 $61.6 Million
Q1 2022 May 16, 2022	BUY	$158.14 - $179.59 $147 Million - $166 Million	926,572 Added 611.82%	1,078,016 $191 Million
Q4 2021 Feb 14, 2022	SELL	$155.93 - $173.01 $72.2 Million - $80.1 Million	-463,026 Reduced 75.35%	151,444 $25.9 Million
Q3 2021 Nov 15, 2021	BUY	$161.5 - $179.47 $17.3 Million - $19.3 Million	107,420 Added 21.19%	614,470 $99.2 Million
Q2 2021 Aug 16, 2021	BUY	$159.48 - $171.07 $53.6 Million - $57.5 Million	336,214 Added 196.81%	507,050 $83.5 Million
Q1 2021 May 17, 2021	SELL	$153.07 - $170.48 $161 Million - $179 Million	-1,049,897 Reduced 86.01%	170,836 $28.1 Million
Q4 2020 Feb 16, 2021	BUY	$137.11 - $157.38 $84.2 Million - $96.6 Million	613,815 Added 101.14%	1,220,733 $192 Million
Q3 2020 Nov 16, 2020	BUY	$140.38 - $153.83 $9.75 Million - $10.7 Million	69,458 Added 12.92%	606,918 $90.4 Million
Q2 2020 Aug 14, 2020	SELL	$128.81 - $155.51 $32.6 Million - $39.4 Million	-253,364 Reduced 32.04%	537,460 $75.6 Million
Q1 2020 May 15, 2020	SELL	$111.14 - $153.99 $278 Million - $385 Million	-2,498,735 Reduced 75.96%	790,824 $104 Million
Q4 2019 Feb 14, 2020	BUY	$127.5 - $146.44 $280 Million - $321 Million	2,192,485 Added 199.85%	3,289,559 $480 Million
Q3 2019 Nov 14, 2019	BUY	$126.95 - $142.14 $85.7 Million - $96 Million	675,207 Added 160.05%	1,097,074 $142 Million
Q2 2019 Aug 14, 2019	SELL	$131.15 - $144.24 $239 Million - $263 Million	-1,824,137 Reduced 81.22%	421,867 $58.8 Million
Q1 2019 May 15, 2019	BUY	$125.72 - $139.79 $182 Million - $203 Million	1,448,890 Added 181.77%	2,246,004 $0
Q4 2018 Feb 14, 2019	BUY	$122.84 - $147.84 $72.2 Million - $86.9 Million	587,666 Added 280.58%	797,114 $103 Million
Q3 2018 Nov 13, 2018	SELL	$121.58 - $142.88 $19.8 Million - $23.2 Million	-162,572 Reduced 43.7%	209,448 $0
Q2 2018 Aug 10, 2018	SELL	$119.4 - $131.76 $59.1 Million - $65.2 Million	-495,056 Reduced 57.09%	372,020 $0
Q1 2018 May 11, 2018	SELL	$125.1 - $148.14 $9.31 Million - $11 Million	-74,418 Reduced 7.9%	867,076 $111 Million
Q4 2017 Feb 09, 2018	BUY	$131.22 - $143.62 $51.2 Million - $56 Million	389,810 Added 70.66%	941,494 $132 Million
Q3 2017 Nov 09, 2017	BUY	$129.47 - $135.38 $71.4 Million - $74.7 Million	551,684	551,684 $71.7 Million

Others Institutions Holding JNJ

# of Institutions

4,253

Shares Held

1.71B

Call Options Held

12.3M

Put Options Held

11.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $401B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account